|
|
||||||||
Ann Thorac Surg 1998;66:606
© 1998 The Society of Thoracic Surgeons
a Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
To the Editor
My colleagues and I thank Dr Massard and his colleagues for responding to our article on the growing teratoma syndrome [1] with a report on an additional patient. Their case makes several important points. (1) Growth during treatment is more common than expected. This may require surgical resection before the completion of chemotherapy. If so, then chemotherapy should be restarted as soon as possible after surgical resection, preferably during the same admission. The need for an urgent operation should be avoided. (2) These tumors can be very large, but still resectable by an experienced surgeon. (3) Resection should only be attempted when the markers have normalized or are clearly in the midst of normal half-life clearance. (4) Regrowth of small, unresected lesions occurs regularly and, in the absence of elevated markers, should be approached surgically. This is an underrecognized problem in the management of all germ cell tumors, not just those arising in the mediastinum.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |